![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
GD Bellward, T Chang, B Rodrigues, JH McNeill, S Maines, DE Ryan, W Levin and PE Thomas
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Hepatic microsomal cytochrome P-450j has been studied using the male spontaneously diabetic BB rat as a model for insulin-dependent diabetes. This approach avoids any direct hepatotoxic effects from chemical diabetogenic agents. Both diabetic rats maintained on insulin and nondiabetic littermates were used as controls. Levels of cytochrome P-450j were increased approximately 3-fold in the diabetics 4 days after the cessation of insulin therapy. In addition, cytochrome P-450j- catalyzed enzymatic activities, aniline hydroxylation, and N- nitrosodimethylamine N-demethylation were increased by the diabetic state at this same time period. Cytochrome P-450f remained at control levels in all groups of animals. In order to test the hypothesis that ketone bodies are involved in the increase in cytochrome P-450j in the diabetic state, plasma beta-hydroxybutyrate levels were monitored. Hepatic aniline hydroxylation, N-nitrosodimethylamine N-demethylation, and cytochrome P-450j levels in individual animals were found to correlate with plasma beta-hydroxybutyrate levels (r = 0.59-0.71 p less than 0.001). In contrast, no significant correlation between levels of cytochrome P-450j and plasma glucose, insulin, or cholesterol was observed in individual animals (r = 0.07-0.23, p greater than 0.4). We conclude that cytochrome P-450j is induced in the livers of spontaneously diabetic rats, and that this induction may be associated directly or indirectly with elevated plasma ketone levels.
This article has been cited by other articles:
|
|
 |
|
  M. A. Abdelmegeed, S. K. Kim, K. J. Woodcroft, and R. F. Novak Acetoacetate Activation of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase in Primary Cultured Rat Hepatocytes: Role of Oxidative Stress J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 728 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Raza, S. K. Prabu, M.-A. Robin, and N. G. Avadhani Elevated Mitochondrial Cytochrome P450 2E1 and Glutathione S-Transferase A4-4 in Streptozotocin-Induced Diabetic Rats: Tissue-Specific Variations and Roles in Oxidative Stress Diabetes, January 1, 2004; 53(1): 185 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Kim, K. J. Woodcroft, and R. F. Novak Insulin and Glucagon Regulation of Glutathione S-Transferase Expression in Primary Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 353 - 361. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Woodcroft and R. F. Novak Insulin Differentially Affects Xenobiotic-Enhanced, Cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A Expression in Primary Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1121 - 1127. [Abstract] [Full Text]
|
|
|
|
 |
|
 H.-M. Peng and M. J. Coon Regulation of Rabbit Cytochrome P450 2E1 Expression in HepG2 Cells by Insulin and Thyroid Hormone Mol. Pharmacol., October 1, 1998; 54(4): 740 - 747. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
